Adicet Bio Analyst Price Targets - Benzinga

Adicet Bio Inc

ACETNASDAQ

Trade with Public

Trade with Public

$7.14

0.314.54%

마지막 업데이트: Sep 30, 8:57 AM

$6.66

-0.17-2.49%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

Adicet Bio Analyst Price Targets - Benzinga

Adicet Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Adicet Bio (ACET).

Price Target Range — 10 Quarters

Analyst Consensus — 8 Analysts

6Buy

2Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$52Upside to Avg. PT+682.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2026	Wedbush	Robert Driscoll	PT Raise	Outperform	$25→$28
Sep 28, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$27→$34
Sep 18, 2026	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$27
Aug 6, 2026	Guggenheim	Yatin Suneja	PT Cut	Buy	$100→$90
May 5, 2026	Jefferies	Anthea Li	Assumes	Buy	$8→$19
Mar 23, 2026	HC Wainwright & Co.	Robert Burns	PT Cut	Buy	$50→$27
Mar 13, 2026	Guggenheim	Yatin Suneja	PT Cut	Buy	$128→$100
Jan 21, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$9→$50
Jan 6, 2026	Canaccord Genuity	John Newman	Maintained	Buy	$128→$18
Nov 7, 2025	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$4→$9
Oct 8, 2025	Guggenheim	Yatin Suneja	PT Raise	Buy	$7→$8
Sep 19, 2025	Guggenheim	Yatin Suneja	Maintained	Buy	$7
Jul 23, 2025	HC Wainwright & Co.	Robert Burns	Assumes	Buy	$4
Mar 21, 2025	Guggenheim	Yatin Suneja	Maintained	Buy	$7
Mar 7, 2025	Citizens Capital Markets	Reni Benjamin	Maintained	Market Perform	—
Mar 7, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Feb 27, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Feb 6, 2025	JMP Securities	Reni Benjamin	Maintained	Market Perform	—
Feb 5, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Dec 19, 2024	HC Wainwright & Co.	Edward White	Maintained	Neutral	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wedbush Maintains Outperform on Adicet Bio, Raises Price Target to $28

Wedbush analyst Robert Driscoll maintains Adicet Bio (NASDAQ:ACET) with a Outperform and raises the price target from $25 to $28.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $34

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $27 to $34.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $27 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $27 price target.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $90

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $100 to $90.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $50 to $27.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $100

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $128 to $100.

Benzinga Newsdesk